Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

J. Washam,A. Hellkamp,Y. Lokhnygina,J. Piccini,S. Berkowitz,C. Nessel,R. Becker,G. Breithardt,K. Fox,J. Halperin,G. Hankey,K. Mahaffey,D. Singer,M. Patel
DOI: https://doi.org/10.1016/j.amjcard.2017.05.026
2017-08-15
Abstract:
What problem does this paper attempt to address?